<table border="0" cellpadding="1" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table 2: CARE - Primary and Secondary Endpoints</caption>
<colgroup>
<col width="40%"></col>
<col align="center" width="15%"></col>
<col align="center" width="15%"></col>
<col align="center" width="15%"></col>
<col align="center" width="15%"></col>
</colgroup>
<thead>
<tr><th align="left" stylecode="Toprule Lrule"> </th><th align="center" colspan="2" stylecode="Toprule Lrule"><content stylecode="bold">Number (%) of Subjects</content></th><th align="left" stylecode="Toprule Lrule"> </th><th align="left" stylecode="Toprule Rrule"> </th></tr>
<tr><th align="left" stylecode="Toprule Lrule" valign="top"><content stylecode="bold">Event</content></th><th align="center" stylecode="Toprule Lrule" valign="top"><content stylecode="bold">Pravastatin<br/> 
 40 mg<br/>   (N=2081)</content></th><th align="center" stylecode="Toprule Lrule" valign="top"><content stylecode="bold">Placebo<br/> 
 (N=2078)</content></th><th align="center" stylecode="Toprule Lrule" valign="top"><content stylecode="bold">Risk<br/> 
 Reduction</content></th><th align="center" stylecode="Toprule Lrule Rrule" valign="top"><content stylecode="bold"><content stylecode="bold italics">P-</content>value</content></th></tr>
</thead>
<tfoot>
<tr><td colspan="5" stylecode="Toprule">*The risk reduction due to treatment with
Pravastatin Sodium Tablets was consistent in both sexes.  </td></tr>
</tfoot>
<tbody>
<tr><td align="left" colspan="5" stylecode="Toprule Lrule Rrule"><content stylecode="bold">Primary Endpoint</content></td></tr>
<tr><td align="left" stylecode="Toprule Lrule">    CHD
mortality or nonfatal MI*</td><td align="center" stylecode="Toprule Lrule">212 (10.2)</td><td align="center" stylecode="Toprule Lrule">274 (13.2)</td><td align="center" stylecode="Toprule Lrule">24%</td><td align="center" stylecode="Toprule Lrule Rrule">0.003</td></tr>
<tr><td align="left" colspan="5" stylecode="Toprule Lrule Rrule"><content stylecode="bold">Secondary Endpoints</content></td></tr>
<tr><td align="left" stylecode="Toprule Lrule">    Myocardial
revascularization<br/>    procedures
(CABG or PTCA)</td><td align="center" stylecode="Toprule Lrule">294 (14.1)</td><td align="center" stylecode="Toprule Lrule">391 (18.8)</td><td align="center" stylecode="Toprule Lrule">27%</td><td align="center" stylecode="Toprule Lrule Rrule">&lt;0.001</td></tr>
<tr><td align="left" stylecode="Toprule Lrule">    Stroke
or TIA</td><td align="center" stylecode="Toprule Lrule">93 (4.5)</td><td align="center" stylecode="Toprule Lrule">124 (6.0)</td><td align="center" stylecode="Toprule Lrule">26%</td><td align="center" stylecode="Toprule Lrule Rrule">0.029</td></tr>
</tbody>
</table>